A Cost-effectiveness Model For The Use Of A Cannabis-derived Oromucosal Spray For The Treatment Of Spasticity In Multiple Sclerosis

Multiple Sclerosis (MS)

Key Findings

Use of THC/CBD has the potential to generate cost savings by significantly improving the symptoms of moderate to severe MS spasticity.

Information and Links


Link: A Cost-effectiveness Model For The Use Of A Cannabis-derived Oromucosal Spray For The Treatment Of Spasticity In Multiple Sclerosis

Year: 2016


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

(THC/CBD) oromucosal spray